Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cns Pharmaceuticals, Inc. (CNSP)  
$0.17 0.00 (0.00%) as of 4:30 Mon 11/28


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 1,330,000
Market Cap: 222.24(K)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.1671 - $0.1671
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CNS Pharmaceuticals is a clinical pharmaceutical company. Co. focuses on the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. Co.'s primary focus is on the development and testing of Berubicin, a development stage anthracycline intended to treat glioblastoma. Berubicin intercalates into deoxyribonucleic acid (DNA) and interrupts topoisomerase II activity, resulting in the inhibition of DNA replication and repair, and RNA and protein synthesis.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 299,998 329,748 357,521
Total Buy Value $0 $90,000 $129,122 $159,009
Total People Bought 0 4 4 4
Total Buy Transactions 0 4 6 10
Total Shares Sold 0 0 0 94,298
Total Sell Value $0 $0 $0 $133,114
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 17
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 39
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Priebe Waldemar   •       •       •   2022-12-09 4 S $2.43 $6,799 I/I (2,798) 231,807     -
   Priebe Waldemar   •       •       •   2022-12-08 4 S $2.40 $13,200 I/I (5,500) 234,605     -
   Priebe Waldemar   •       •       •   2022-12-07 4 S $2.46 $13,530 I/I (5,500) 240,105     -
   Priebe Waldemar   •       •       •   2022-12-06 4 S $2.47 $13,585 I/I (5,500) 245,605     -
   Downs Christopher Chief Financial Officer   •       –      –    2022-03-11 4 A $0.31 $10,230 D/D 33,000 184,500     -
   Evans Carl Anthony Director   –       •      –    2022-03-08 4 A $0.27 $1,005 D/D 3,750 3,750     -
   Keyes Jeffry R. Director   –       •      –    2022-03-07 4 A $0.30 $3,294 D/D 11,100 11,100     -
   Climaco John M Chief Executive Officer   •       •      –    2022-03-07 4 A $0.28 $9,835 D/D 35,000 940,298     -
   Downs Christopher Chief Financial Officer   •       –      –    2021-12-06 4 B $0.94 $4,702 D/D 5,000 151,500 2.66 -63%     
   Climaco John M Chief Executive Officer   •       •      –    2021-11-16 4 A $1.28 $6,400 D/D 5,000 905,298     -
   Downs Christopher Chief Financial Officer   •       –      –    2020-08-24 4 B $2.04 $289,680 D/D 142,000 142,000 2.74 -19%     
   Priebe Waldemar 10% Owner   –       –       •   2020-05-05 4 D $0.00 $0 I/I (1,495,867) 7,533,133     -
   Climaco John M Chief Executive OfficerOfficer   •       •      –    2019-11-07 3 IO $0.00 $0 D/D 0 900,000     -
   Priebe Waldemar 10% Owner   –       –       •   2019-11-07 3 IO $0.00 $0 I/I 0 9,029,000     -

  39 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed